Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 238495, 9 pages
http://dx.doi.org/10.1155/2015/238495
Research Article

Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis

1Research Center for TCM Complexity System, Shanghai University of TCM, Shanghai 201203, China
2Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of TCM, Shanghai 201203, China
3Shanghai University of TCM, Shanghai 201203, China

Received 4 August 2014; Revised 20 September 2014; Accepted 21 September 2014

Academic Editor: Qing He

Copyright © 2015 Qi-Long Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Hsu, C.-L. Lai, and M.-F. Yuen, “Update on the risk of hepatocellular carcinoma in chronic hepatitis B virus infection,” Current Hepatitis Reports, vol. 10, no. 2, pp. 106–111, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. F. E. de Jongh, H. L. A. Janssen, R. A. de Man, W. C. J. Hop, S. W. Schalm, and M. van Blankenstein, “Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver,” Gastroenterology, vol. 103, no. 5, pp. 1630–1635, 1992. View at Google Scholar · View at Scopus
  3. T. Yang, D.-P. Shen, Q.-L. Wang, Y.-Y. Tao, and C.-H. Liu, “Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components,” Journal of Ethnopharmacology, vol. 148, no. 2, pp. 691–700, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y.-H. Jia, R.-Q. Wang, H.-M. Mi et al., “Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice,” Lipids in Health and Disease, vol. 11, article 45, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Q.-L. Wang, Y.-Y. Tao, L. Shen, H.-Y. Cui, and C.-H. Liu, “Chinese herbal medicine fuzheng huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/ smads signaling pathway,” Journal of Chinese Integrative Medicine, vol. 10, no. 5, pp. 561–568, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. P. Bartel, “MicroRNAs: target recognition and regulatory functions,” Cell, vol. 136, no. 2, pp. 215–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Hou, L. Lin, W. Zhou et al., “Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma,” Cancer Cell, vol. 19, no. 2, pp. 232–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Forman, A. Legesse-Miller, and H. A. Coller, “A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 39, pp. 14879–14884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. R. Lytle, T. A. Yario, and J. A. Steitz, “Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 23, pp. 9667–9672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, “The impact of microRNAs on protein output,” Nature, vol. 455, no. 7209, pp. 64–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., “Circulating microRNAs as stable blood-based markers for cancer detection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513–10518, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. G. Schrauder, R. Strick, R. Schulz-Wendtland et al., “Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection,” PLoS ONE, vol. 7, no. 1, Article ID e29770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Zhuang, “Guideline on prevention and treatment of chronic hepatitis B in China (2005),” Chinese Medical Journal, vol. 120, no. 24, pp. 2159–2173, 2007. View at Google Scholar · View at Scopus
  15. T. Vergoulis, I. S. Vlachos, P. Alexiou et al., “TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support,” Nucleic Acids Research, vol. 40, no. 1, pp. D222–D229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Xiao, Z. Zuo, G. Cai, S. Kang, X. Gao, and T. Li, “miRecords: an integrated resource for microRNA-target interactions,” Nucleic Acids Research, vol. 37, no. 1, pp. D105–D110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S.-D. Hsu, F.-M. Lin, W.-Y. Wu et al., “MiRTarBase: a database curates experimentally validated microRNA-target interactions,” Nucleic Acids Research, vol. 39, supplement 1, pp. D163–D169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Guo, Y. Feng, N. S. Trivedi, and S. Huang, “Medusa structure of the gene regulatory network: dominance of transcription factors in cancer subtype classification,” Experimental Biology and Medicine, vol. 236, no. 5, pp. 628–636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Nepusz, H. Yu, and A. Paccanaro, “Detecting overlapping protein complexes in protein-protein interaction networks,” Nature Methods, vol. 9, no. 5, pp. 471–472, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Zheng, W. P. Tansey, S. W. Hiebert, and Z. Zhao, “Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma,” BMC Medical Genomics, vol. 4, article 62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Chen, R. Liu, Z.-P. Liu, M. Li, and K. Aihara, “Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers,” Scientific Reports, vol. 2, article 342, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Miller, S. Horvath, and D. H. Geschwind, “Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 28, pp. 12698–12703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. D. He, Z. P. Liu, M. Honda, S. Kaneko, and L. Chen, “Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma,” Journal of Molecular Cell Biology, vol. 4, no. 3, pp. 140–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Spaziani, A. Alisi, D. Sanna, and C. Balsano, “Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1,” The Journal of Biological Chemistry, vol. 281, no. 16, pp. 10983–10989, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. H. Stegh, “Targeting the p53 signaling pathway in cancer therapy—the promises, challenges and perils,” Expert Opinion on Therapeutic Targets, vol. 16, no. 1, pp. 67–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Fabregat, J. Fernando, J. Mainez, and P. Sancho, “TGF-Beta signaling in cancer treatment,” Current Pharmaceutical Design, vol. 20, no. 17, pp. 2934–2947, 2014. View at Publisher · View at Google Scholar
  29. L. Zhang, F. Zhou, A. Garcia deVinuesa, and et al, “TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis,” Molecular Cell, vol. 51, no. 5, pp. 559–572, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Saito, H. I. Suzuki, M. Horie et al., “An integrated expression profiling reveals target genes of TGF-beta and TNF-alpha possibly mediated by microRNAs in lung cancer cells,” PLoS ONE, vol. 8, no. 2, Article ID e56587, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Lv, J. Qin, R. Yi et al., “Crkl efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma,” Journal of Molecular Neuroscience, vol. 51, no. 3, pp. 1046–1051, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Mu, S. Lin, J. Yang et al., “TGF-β signaling is often attenuated during Hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells,” PLoS ONE, vol. 8, no. 5, Article ID e63436, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Dooley and P. ten Dijke, “TGF-β in progression of liver disease,” Cell and Tissue Research, vol. 347, no. 1, pp. 245–256, 2012. View at Publisher · View at Google Scholar · View at Scopus